Screening of Antiviral Components of Yinhuapinggan Granule and Protective Effects of Yinhuapinggan Granule on MDCK Cells with Influenza A/H1N1 Virus

Figure 3

The therapeutic effect of YHPG and ribavirin granules on influenza virus: (a) control group; (b) mock groups; (c) ribavirin group (0.780 mg·mL^-1); (d) high-dose YHPG group (0.625 mg·mL^-1); (e) medium-dose YHPG group (0.313 mg·mL^-1); (f) low-dose YHPG group (0.156 mg·mL^-1).

(a)

(b)

(c)

(d)

(e)

(f)